Recent Updates
Recently added Catalysts
AIFF Positive Sentiment

Zeto inks partnership with Firefly Neuroscience

Thursday, September 12, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Zeto has entered a strategic partnership with Firefly Neuroscience to enhance the distribution of its FDA-cleared EEG headset devices. Firefly will serve as a non-exclusive distributor for Zeto's products. This collaboration will also integrate Firefly's Brain Network Analytics technology with Zeto's EEG platforms, which are already in use at over 200 hospitals and neurology offices nationwide.
Price reaction · baseline $3.78 (2024-09-12T14:05:00.000Z) · hit during market hours · 1 other AIFF headline(s) in the window, move may be shared
day 0 close · peak
-2.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Zeto's EEG headset devices are FDA-cleared.
  • Partnership enhances distribution capabilities.
  • Integration with Firefly's Brain Network Analytics technology.

Full Press Release Details

Zeto has formed a partnership with Firefly Neuroscience that boosts the distribution of Zeto’s FDA-cleared EEG headset devices.
The strategic partnership, announced yesterday, makes Buffalo, New York–based Firefly a non-exclusive distributor of Santa Clara, California–based Zeto’s headset. The collaboration also includes the integration of Firefly’s proprietary Brain Network Analytics (BNA) technology with the EEG platforms, presently used in more than 200 hospitals and neurology offices across the country.
Read Article

Frequently Asked Questions

What is the purpose of Zeto's partnership with Firefly?

The partnership aims to boost the distribution of Zeto's FDA-cleared EEG headset devices.

Where is Firefly Neuroscience based?

Firefly Neuroscience is based in Buffalo, New York.

What technology will be integrated with Zeto's EEG platforms?

Firefly's proprietary Brain Network Analytics technology will be integrated.

How many hospitals use Zeto's EEG devices?

Zeto's EEG devices are currently used in over 200 hospitals and neurology offices.

ShareAdd on Google
Tags: AIFF Viatris Investor Conferences Healthcare Zeto Firefly Neuroscience EEG headset Brain Network Analytics FDA-cleared devices
Last updated: Sep 12, 2024

Biotech snapshot

Cash runway
$3M liquidity · $1M/mo burn
~2 mo
High dilution risk